1 Study Coverage
1.1 Veterinary Vaccines Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million) Introduction
1.2 Global Veterinary Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global Veterinary Vaccines Market Size for the Year 2017-2028
1.2.2 Global Veterinary Vaccines Market Size for the Year 2017-2028
1.3 Veterinary Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Veterinary Vaccines in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Veterinary Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Veterinary Vaccines Market Dynamics
1.4.1 Veterinary Vaccines Industry Trends
1.4.2 Veterinary Vaccines Market Drivers
1.4.3 Veterinary Vaccines Market Challenges
1.4.4 Veterinary Vaccines Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Veterinary Vaccines by Type
2.1 Veterinary Vaccines Market Segment by Type
2.1.1 Inactivated Vaccines
2.1.2 Live Attenuated Vaccines
2.1.3 Conjugate Vaccines
2.1.4 Toxoid Vaccines
2.1.5 Recombinant Vaccines
2.1.6 DNA Vaccines
2.1.7 Others
2.2 Global Veterinary Vaccines Market Size by Type (2017, 2022 & 2028)
2.3 Global Veterinary Vaccines Market Size by Type (2017-2028)
2.4 United States Veterinary Vaccines Market Size by Type (2017, 2022 & 2028)
2.5 United States Veterinary Vaccines Market Size by Type (2017-2028)
3 Veterinary Vaccines by Application
3.1 Veterinary Vaccines Market Segment by Application
3.1.1 Veterinary Clinic
3.1.2 Veterinary Hospital
3.1.3 Veterinary Research Institute
3.1.4 Retail Pharmacy
3.1.5 Others
3.2 Global Veterinary Vaccines Market Size by Application (2017, 2022 & 2028)
3.3 Global Veterinary Vaccines Market Size by Application (2017-2028)
3.4 United States Veterinary Vaccines Market Size by Application (2017, 2022 & 2028)
3.5 United States Veterinary Vaccines Market Size by Application (2017-2028)
4 Global Veterinary Vaccines Competitor Landscape by Company
4.1 Global Veterinary Vaccines Market Size by Company
4.1.1 Top Global Veterinary Vaccines Companies Ranked by Revenue (2021)
4.1.2 Global Veterinary Vaccines Revenue by Player (2017-2022)
4.2 Global Veterinary Vaccines Concentration Ratio (CR)
4.2.1 Veterinary Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Veterinary Vaccines in 2021
4.2.3 Global Veterinary Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Veterinary Vaccines Headquarters, Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million) Type
4.3.1 Global Veterinary Vaccines Headquarters and Area Served
4.3.2 Global Veterinary Vaccines Companies Revenue in Veterinary Vaccines Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Veterinary Vaccines Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Veterinary Vaccines Market Size by Company
4.5.1 Top Veterinary Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States Veterinary Vaccines Revenue by Players (2020, 2021 & 2022)
5 Global Veterinary Vaccines Market Size by Region
5.1 Global Veterinary Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Veterinary Vaccines Market Size by Region (2017-2028)
5.2.1 Global Veterinary Vaccines Market Size by Region: 2017-2022
5.2.2 Global Veterinary Vaccines Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Veterinary Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America Veterinary Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Veterinary Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Veterinary Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Veterinary Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe Veterinary Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Veterinary Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America Veterinary Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Veterinary Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Veterinary Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Elanco
7.1.1 Elanco Company Details
7.1.2 Elanco Business Overview
7.1.3 Elanco Veterinary Vaccines Introduction
7.1.4 Elanco Revenue in Veterinary Vaccines Business (2017-2022)
7.1.5 Elanco Recent Development
7.2 Merck
7.2.1 Merck Company Details
7.2.2 Merck Business Overview
7.2.3 Merck Veterinary Vaccines Introduction
7.2.4 Merck Revenue in Veterinary Vaccines Business (2017-2022)
7.2.5 Merck Recent Development
7.3 Merial
7.3.1 Merial Company Details
7.3.2 Merial Business Overview
7.3.3 Merial Veterinary Vaccines Introduction
7.3.4 Merial Revenue in Veterinary Vaccines Business (2017-2022)
7.3.5 Merial Recent Development
7.4 Zoetis
7.4.1 Zoetis Company Details
7.4.2 Zoetis Business Overview
7.4.3 Zoetis Veterinary Vaccines Introduction
7.4.4 Zoetis Revenue in Veterinary Vaccines Business (2017-2022)
7.4.5 Zoetis Recent Development
7.5 Advaxis
7.5.1 Advaxis Company Details
7.5.2 Advaxis Business Overview
7.5.3 Advaxis Veterinary Vaccines Introduction
7.5.4 Advaxis Revenue in Veterinary Vaccines Business (2017-2022)
7.5.5 Advaxis Recent Development
7.6 AmpliPhi Biosciences
7.6.1 AmpliPhi Biosciences Company Details
7.6.2 AmpliPhi Biosciences Business Overview
7.6.3 AmpliPhi Biosciences Veterinary Vaccines Introduction
7.6.4 AmpliPhi Biosciences Revenue in Veterinary Vaccines Business (2017-2022)
7.6.5 AmpliPhi Biosciences Recent Development
7.7 Aratana Therapeutics
7.7.1 Aratana Therapeutics Company Details
7.7.2 Aratana Therapeutics Business Overview
7.7.3 Aratana Therapeutics Veterinary Vaccines Introduction
7.7.4 Aratana Therapeutics Revenue in Veterinary Vaccines Business (2017-2022)
7.7.5 Aratana Therapeutics Recent Development
7.8 ARKO Labs
7.8.1 ARKO Labs Company Details
7.8.2 ARKO Labs Business Overview
7.8.3 ARKO Labs Veterinary Vaccines Introduction
7.8.4 ARKO Labs Revenue in Veterinary Vaccines Business (2017-2022)
7.8.5 ARKO Labs Recent Development
7.9 Bayer
7.9.1 Bayer Company Details
7.9.2 Bayer Business Overview
7.9.3 Bayer Veterinary Vaccines Introduction
7.9.4 Bayer Revenue in Veterinary Vaccines Business (2017-2022)
7.9.5 Bayer Recent Development
7.10 CanFel Therapeutics
7.10.1 CanFel Therapeutics Company Details
7.10.2 CanFel Therapeutics Business Overview
7.10.3 CanFel Therapeutics Veterinary Vaccines Introduction
7.10.4 CanFel Therapeutics Revenue in Veterinary Vaccines Business (2017-2022)
7.10.5 CanFel Therapeutics Recent Development
7.11 Ceva Animal Health
7.11.1 Ceva Animal Health Company Details
7.11.2 Ceva Animal Health Business Overview
7.11.3 Ceva Animal Health Veterinary Vaccines Introduction
7.11.4 Ceva Animal Health Revenue in Veterinary Vaccines Business (2017-2022)
7.11.5 Ceva Animal Health Recent Development
7.12 Colorado Serum
7.12.1 Colorado Serum Company Details
7.12.2 Colorado Serum Business Overview
7.12.3 Colorado Serum Veterinary Vaccines Introduction
7.12.4 Colorado Serum Revenue in Veterinary Vaccines Business (2017-2022)
7.12.5 Colorado Serum Recent Development
7.13 Epitopix
7.13.1 Epitopix Company Details
7.13.2 Epitopix Business Overview
7.13.3 Epitopix Veterinary Vaccines Introduction
7.13.4 Epitopix Revenue in Veterinary Vaccines Business (2017-2022)
7.13.5 Epitopix Recent Development
7.14 Genus
7.14.1 Genus Company Details
7.14.2 Genus Business Overview
7.14.3 Genus Veterinary Vaccines Introduction
7.14.4 Genus Revenue in Veterinary Vaccines Business (2017-2022)
7.14.5 Genus Recent Development
7.15 Hygieia Biological Laboratories
7.15.1 Hygieia Biological Laboratories Company Details
7.15.2 Hygieia Biological Laboratories Business Overview
7.15.3 Hygieia Biological Laboratories Veterinary Vaccines Introduction
7.15.4 Hygieia Biological Laboratories Revenue in Veterinary Vaccines Business (2017-2022)
7.15.5 Hygieia Biological Laboratories Recent Development
7.16 ImmuCell
7.16.1 ImmuCell Company Details
7.16.2 ImmuCell Business Overview
7.16.3 ImmuCell Veterinary Vaccines Introduction
7.16.4 ImmuCell Revenue in Veterinary Vaccines Business (2017-2022)
7.16.5 ImmuCell Recent Development
7.17 Nexvet
7.17.1 Nexvet Company Details
7.17.2 Nexvet Business Overview
7.17.3 Nexvet Veterinary Vaccines Introduction
7.17.4 Nexvet Revenue in Veterinary Vaccines Business (2017-2022)
7.17.5 Nexvet Recent Development
7.18 Nuovo Biologics
7.18.1 Nuovo Biologics Company Details
7.18.2 Nuovo Biologics Business Overview
7.18.3 Nuovo Biologics Veterinary Vaccines Introduction
7.18.4 Nuovo Biologics Revenue in Veterinary Vaccines Business (2017-2022)
7.18.5 Nuovo Biologics Recent Development
7.19 UBI
7.19.1 UBI Company Details
7.19.2 UBI Business Overview
7.19.3 UBI Veterinary Vaccines Introduction
7.19.4 UBI Revenue in Veterinary Vaccines Business (2017-2022)
7.19.5 UBI Recent Development
7.20 Valneva
7.20.1 Valneva Company Details
7.20.2 Valneva Business Overview
7.20.3 Valneva Veterinary Vaccines Introduction
7.20.4 Valneva Revenue in Veterinary Vaccines Business (2017-2022)
7.20.5 Valneva Recent Development
7.21 Vetoquinol
7.21.1 Vetoquinol Company Details
7.21.2 Vetoquinol Business Overview
7.21.3 Vetoquinol Veterinary Vaccines Introduction
7.21.4 Vetoquinol Revenue in Veterinary Vaccines Business (2017-2022)
7.21.5 Vetoquinol Recent Development
7.22 Virbac
7.22.1 Virbac Company Details
7.22.2 Virbac Business Overview
7.22.3 Virbac Veterinary Vaccines Introduction
7.22.4 Virbac Revenue in Veterinary Vaccines Business (2017-2022)
7.22.5 Virbac Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
